Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes

    ... effects of azacitidine in higher-risk myelodysplastic syndromes were established in mainly Caucasian populations. Because of ...

    Research Article last updated 02/03/2017 - 10:05am.

  2. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes

    ... OBJECTIVES: Thirty to 80 per cent of patients with myelodysplastic syndromes (MDS) become transfusion-dependent and are at risk for red ...

    Research Article last updated 02/03/2017 - 11:00am.

  3. Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure

    ... The treatment of patients with myelodysplastic syndromes (MDSs) has hinged primarily on supportive care (ie, blood ...

    Research Article last updated 01/26/2017 - 10:36am.

  4. Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes

    ... January 1, 2017 Myelodysplastic syndromes (MDS) represent a clonal hematopoietic stem cell disorder ...

    Research Article last updated 02/01/2017 - 8:17am.

  5. Therapy-related myelodysplastic syndromes, or are they?

    ... The incidence of therapy-related myelodysplastic syndromes (t-MDS) is increasing as the number of cancer survivors is ...

    Research Article last updated 01/26/2017 - 10:08am.

  6. Recurrent Cytogenetic Abnormalities in Myelodysplastic Syndromes

    ... role in diagnosis, classification, and prognosis of myelodysplastic syndromes (MDS). Some cytogenetic abnormalities are sufficiently ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 01/26/2017 - 11:01am.

  7. Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights

    ... 14, 2016 Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic neoplasms ocurring ...

    Research Article last updated 02/01/2017 - 8:15am.

  8. Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece

    ... PURPOSE: We have observed an increasing incidence of myelodysplastic syndromes (MDS) in the geographic area of Western Greece during the past ...

    Research Article last updated 02/03/2017 - 10:41am.

  9. Use of eltrombopag for treatment of myelodysplastic syndromes

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 03/22/2017 - 10:31am.

  10. Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes.

    ... January 1, 2017 Myelodysplastic syndromes (MDS) are a group of acquired hematopoietic stem cell disorders ...

    Research Article last updated 01/24/2017 - 7:25am.